Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts. View our terms of use: https://flexiontherapeutics.com/terms-of-use/
Looking for a particular Flexion Therapeutics employee's phone or email?
The Flexion Therapeutics annual revenue was $33.5 million in 2026.
Melissa Layman is the Chief Commercial Officer of Flexion Therapeutics.
22 people are employed at Flexion Therapeutics.
Flexion Therapeutics is based in Burlington, Massachusetts.
The NAICS codes for Flexion Therapeutics are [32541, 3254, 325414, 325413, 32, 325].
The SIC codes for Flexion Therapeutics are [283, 28].